Among the 61% who have adjusted their holiday shopping plans due to tariff concerns, one quarter (25%) started holiday shopping earlier this year to ...
The Phase 2a data1 from initial dosing cohorts marks the first robust demonstration of an oral OX2R agonist addressing wakefulness needs across NT1 patients, who lack endogenous orexin, and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback